UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016267
Receipt number R000018878
Scientific Title The effect of carnitine for intermittent claudication of peripheral arterial disease patient with sarcopenia and carnitine deficiency
Date of disclosure of the study information 2015/01/26
Last modified on 2017/07/24 10:18:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of carnitine for intermittent claudication of peripheral arterial disease patient with sarcopenia and carnitine deficiency

Acronym

The effect of carnitine for intermittent claudication of peripheral arterial disease patient with sarcopenia and carnitine deficiency

Scientific Title

The effect of carnitine for intermittent claudication of peripheral arterial disease patient with sarcopenia and carnitine deficiency

Scientific Title:Acronym

The effect of carnitine for intermittent claudication of peripheral arterial disease patient with sarcopenia and carnitine deficiency

Region

Japan


Condition

Condition

Peripheral arterial disease(PAD), Arteriosclerosis obliterans(ASO)

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the proportion of sarcopenia in PAD patients, and the effect of carnitine for intermittent claudication of peripheral arterial disease patient with sarcopenia and carnitine deficiency

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pretreatment of carnitine: cross-sectional areas of skeletal muscle at the thigh and lumbar part, serum carnitine level, absolute claudication distance, symptom, ABI
Post treatment of carnitine: serum carnitine level, absolute claudication distance, symptom, cross-sectional areas of skeletal muscle at the thigh and lumbar part at 6 months after carnitine treatment

Key secondary outcomes

Adverse event, serum carnitine level, absolute claudication distance, symptom at 4 weeks and 3 months after carnitine treatment


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

carnitine

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) PAD with intermittent claudication
2) PAD patients desiring for medical treatment
3) The patients obtained informed consent
4) The age over 40 years old
5) Insufficiency of treatment with cilostazole or the difficulty of taking the cilostazole due to side effect

Key exclusion criteria

1) Acute limb ischemia
2) Preferred revascularization for symptoms
3) Comorbidity taking precedence of treatment
4) Bleeding disorders
5) Congestive heart failure
6) Drug allergy of cilostazole or carnitine
7) Pregnant female
8) The patient judged inappropriate by the doctor

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshihiko Maehara

Organization

Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Division name

Department of Surgery and Science

Zip code


Address

3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

TEL

0926425466

Email

maehara@surg2.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takuya Matsumoto

Organization

Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Division name

Department of Surgery and Science

Zip code


Address

3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

TEL

092-642-5466

Homepage URL


Email

takum@surg2.med.kyushu-u.ac.jp


Sponsor or person

Institute

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Institute

Department

Personal name



Funding Source

Organization

Kyushu University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 01 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 26 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 19 Day

Last modified on

2017 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018878


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name